Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• Long non-coding RNAs (lncRNAs) are critical regulators of gene expression and chromatin interactions.
• lncRNAs play significant roles in cancer progression, making them attractive therapeutic targets.
• CRISPR interference (CRISPRi) offers a precise method for functional analysis of nuclear lncRNAs.

Purpose of the Study:

• To develop and validate a dual CRISPRi system for combinatorial targeting of lncRNAs in human melanoma cells.
• To enable synthetic lethal screening of lncRNA pairs to identify interactions essential for cancer cell survival.
• To provide a novel tool for investigating lncRNA functions in cancer biology.

Main Methods:

• Utilized orthogonal CRISPRi technologies (Staphylococcus aureus and Streptococcus pyogenes) based on dCas9-KRAB-MeCP2.
• Optimized a dual CRISPRi system for simultaneous knockdown of multiple lncRNAs.
• Applied the system for combinatorial gene knockdown and synthetic lethal screening in melanoma cells.

Main Results:

• Demonstrated the functionality of the dual CRISPRi system for combinatorial lncRNA targeting.
• Successfully facilitated screening for synthetic lethality between pairs of lncRNAs.
• Highlighted the system's capability in identifying critical cancer-specific lncRNA interactions.

Conclusions:

• The developed dual CRISPRi system is a powerful tool for functional genomics of lncRNAs in cancer.
• This approach can uncover novel lncRNA interactions vital for melanoma cell survival.
• The findings offer potential for developing new therapeutic strategies targeting lncRNA interactions in cancer.